DI BELLO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 7.112
EU - Europa 1.915
AS - Asia 835
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 9.873
Nazione #
US - Stati Uniti d'America 7.104
IT - Italia 826
CN - Cina 389
SG - Singapore 314
FI - Finlandia 236
UA - Ucraina 229
DE - Germania 208
FR - Francia 185
SE - Svezia 133
VN - Vietnam 91
GB - Regno Unito 57
IN - India 26
IE - Irlanda 13
CA - Canada 7
CZ - Repubblica Ceca 6
EU - Europa 5
IQ - Iraq 4
PT - Portogallo 4
RO - Romania 4
TR - Turchia 4
CH - Svizzera 3
IR - Iran 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
AT - Austria 2
BR - Brasile 2
ES - Italia 2
JP - Giappone 2
NL - Olanda 2
BZ - Belize 1
HK - Hong Kong 1
PL - Polonia 1
RU - Federazione Russa 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 9.873
Città #
Jacksonville 987
Woodbridge 924
Ann Arbor 668
Fairfield 658
Chandler 607
Houston 478
Wilmington 314
Ashburn 312
Singapore 244
Princeton 238
Seattle 221
Boardman 212
Cambridge 184
Santa Clara 161
Medford 98
Beijing 91
Dong Ket 91
Helsinki 82
Nanjing 79
Padova 78
San Diego 70
Roxbury 64
Des Moines 52
Milan 40
Guangzhou 35
Hebei 35
Rome 35
Redwood City 29
Norwalk 28
Nanchang 22
Shenyang 22
Jiaxing 20
Palermo 18
Tianjin 15
Dallas 14
Florence 14
Dublin 13
Changsha 12
London 12
Naples 12
Ogden 12
Paris 11
Pisa 11
Bologna 9
Kharkiv 9
Pune 9
Turin 9
Vicenza 9
Rockville 8
Pescara 7
Reggio Calabria 7
Bari 6
Brno 6
Genoa 6
Montebelluna 6
Taranto 6
Treviso 6
Verona 6
Lecce 5
Noicattaro 5
Schio 5
Shanghai 5
Adelfia 4
Bagnaria Arsa 4
Catania 4
Como 4
Conegliano 4
Dolo 4
Jinan 4
Kozhikode 4
L’Aquila 4
Morcone 4
Parma 4
Pignone 4
Vigonza 4
Bacchereto 3
Borås 3
Brendola 3
Cariati 3
Castelvetrano 3
Chieti 3
Corigliano Calabro 3
Giulianova 3
Gravina In Puglia 3
Ispica 3
Kilburn 3
Lamezia Terme 3
Legnaro 3
Los Angeles 3
Modena 3
Montecatini Terme 3
Monza 3
New York 3
Nürnberg 3
Orange 3
Paterno 3
Perugia 3
Pinehaven 3
Preganziol 3
Reggio Emilia 3
Totale 7.579
Nome #
Biomateriali. Dalla scienza dei materiali alle applicazioni cliniche 747
Interazioni tra biomateriali e tessuti 125
A novel Algorithm for the Coupling Control in Solid Phase Peptide Synthesis 121
Automation of the liquid-phase synthesis of biopolymers 120
Novel osteoblast-adhesive peptides for dental/orthopedic biomaterials 119
BINDING TO CD4 OF SYNTHETIC PEPTIDES PATTERNED ON THE PRINCIPAL NEUTRALIZING DOMAIN OF THE HIV-1 ENVELOPE PROTEIN 117
Effect of synthetic peptides on osteoblast adhesion 117
Peptidi della vitronectina e loro impiego terapeutico nella adesione degli osteoblasti 116
Surface treatments and roughness properties of Ti-based biomaterials 112
AFFINITY-CHROMATOGRAPHY OF CD4 LIGANDS 108
Improvement of Anselme's adhesion model for evaluating human osteoblast response to peptide-grafted titanium surfaces 106
Adhesion and spreading of human osteoblasts on biomimetic glass surfaces evaluated by Total Internal Reflection Fluorescence (TIRF) microscopy 105
Anti-HIV-1 activity of CD4 synthetic oligopeptides representative of the putative gp120 binding site 105
Synthetic Peptides Derived from the Angiostatin K4 Domain Inhibit Endothelial Cell Migration 103
CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation 102
Is the V3 loop involved in HIV binding to CD4? 102
Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides 101
Covalent surface modification of titanium oxide with different adhesive peptides: surface characterization and osteoblast-like cell adhesion. 100
Design, synthesis and CD4 binding studies of a fluorescent analogue of a peptide that enhances HIV-1 infectivity 100
Self-assembling peptides: A combined XPS and NEXAFS investigation on the structure of two dipeptides Ala-Glu, Ala-Lys 97
STRUCTURAL STUDIES ON SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HIV-1 GP120 THAT BIND TO CD4 AND ENHANCE HIV-1 INFECTION 93
Structural investigation and kinetic characterization of potential cleavage sites of HIV gp160 by human Furin and PC1 93
Evaluation of human osteoblast-like cell adhesion strength on Ti substrates functionalized by bioactive peptide grafting 92
The structure of synthetic peptides from the Principal Neutralizing Domain of HIV-1 gp120 affects binding to CD4 and viral infectivity 91
SPPS of Difficult Sequences: a Comparison of Chemical Conditions, Synthetic Strategies and On-line Monitoring 91
Structural studies on model peptides reproducing the processing site of the ocytocin/neurophysin precursor 90
SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENHANCE HIV-1 INFECTION THROUGH A CD4-DEPENDENT MECHANISM 90
Peptides adsorption on TiO2 and Au: molecular organization investigated by NEXAFS, XPS and IR 89
Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 89
Synthetic Peptides Derived from the Principal Neutralizing Domain Modulate HIV-1 Infection 88
Conformational analysis of heparin binding peptides 86
Conformational studies on synthetic peptides reproducing the dibasic processing site of pro-ocytocin-neurophysin 86
In vitro and in vivo pro-angiogenic effects of thymosin-beta4-derived peptides 86
Automated biopolymer synthesis 84
SPPS of difficult sequences: a comparison of chemical conditions, synthetic strategies and on-line monitoring 84
Semi-automatic detection of the reaction between hemocyanin and oxygen 82
Mining genomic expression data 82
Application of statistical process control to solid-phase synthesis of peptides 82
Synthetic peptides for study of human immunodeficiency virus infection 82
A batch-type system for the large-scale solid-phase oligonucleotide synthesis 81
Investigations Using Photo Affinity Labeled Analogues Confirm the Binding between sCD4 and the PND of HIV-1, MN 81
Fermentation diagnosis by multivariate statistical analysis 81
Coupling control in solid-phase peptide synthesis and on-line monitoring 80
Assessment of novel chemical strategies for covalent attachment of adhesive peptides to rough titanium surfaces: XPS analysis and biological evaluation 80
Conformation and bioactive properties of novel osteoblast-adhesive peptides for biomaterial design 77
Heparin enhances the furin cleavage of HIV-1 gp160 peptides 77
A method for the final yield prediction and for the automatic control of solid-phase peptide synthesis 75
A novel prototype for automated synthesis of peptides 74
Extracting dynamic patterns from gene expression data by the analysis of an autoassociative neural network architecture 73
Synthesis, characterization and conformational analysis of gp120-derived synthetic peptides that specifically enhance HIV-1 infectivity 73
The use of synthetic peptides in the study of HIV-1/target cell interactions 72
EVIDENCE FOR THE PRESENCE OF A SECONDARY STRUCTURE AT THE DIBASIC PROCESSING SITE OF PROHORMONE - THE PRO-OXYTOCIN MODEL 70
The structure of synthetic peptides from the Principal Neutralizing Domain of gp120 affects binding to CD4 and viral infectivity 70
Furin-mediated Cleavage of Natural and Modified gp160 Peptides 70
Anti-HIV-activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1 70
Conformational study of self-assembling peptides 70
Biological and Confornational Studies on Analogues of a Synthetic Peptide Enhancing HIV-1 Infection 70
Anti HIV-1 Activities of CD4 Synthetic Oligopeptides 70
Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 3: Role of site-specific mutations 69
Structural Investigation of the HIV-1 Envelope Glycoprotein gp160 Cleavage Site, 2: Relevance of an N-Terminal Helix 69
Processo di maturazione della glicoproteina gp160: analisi conformazionale e studi cinetici su peptidi riproducenti il sito di clivaggio enzimatico di gp160 68
MINIMAL SEQUENCE REQUIREMENTS FOR SYNTHETIC PEPTIDES DERIVED FROM THE V3 LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO ENHANCE HIV-1 BINDING TO CELLS AND INFECTION 67
Thin films of a self-assembling peptide on TiO2 and Au studied by NEXAFS, XPS and IR spectroscopies 67
Synthetic peptides derived from the PND of HIV-1 enhance virus infection: role of charged and aromatic amino acids in determining biological and conformational properties 67
Evidence for the Presence of a Secondary Binding Site Between HIV-MN-gp120 PND and the CD4 CDR3 Region 66
Large-scale automated biopolymers synthesis 66
Dental implant osseo-integration: a coupled biochemical and biomechanical approach 65
Peptidi Sintetici Derivati dal V3 Loop di HIV-1 Modulano l'Infezione virale 64
A Type-II-b Turn, Proline-Containing, Cyclic Pentapeptide as a Building Block for the Construction of Models of the Cleavage Site of Pro-ocytocin 64
Synthetic Peptides Derived From the Principal Neutralizing Domain (PND) of Human Immunodeficiency Virus Type 1 (HIV-1) Enhance HIV-1 Infection 63
Synthetic peptides suitable to enhance HIV-1 virus infectivity 63
Development of a prototype for the automated solid-phase synthesis of peptides 62
Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site. solution conformation of a 41-MER peptide 62
Studio dei Fattori che Determinano in Vitro l'Effetto Attivante Dose-Dipendente e Non Virus-Ristretto di Peptidi del PND 59
The structure of synthetic peptides from the Principal Neutralizing Domain of gp120 affects binding to CD4 and viral infectivity 58
Studi con marcatori di fotoaffinità  confermano il binding tra sCD4 e il PND di HIV-1 MN 57
In-line monitoring of the key reactions in automated solid-phase peptide synthesis 56
Synthetic peptides suitable to enhance HIV-1 virus infectivity 55
Thin films of a self-assembling peptide on TiO2 and Au studied by NEXAFS, XPS and IR spectroscopies 55
Automated liquid-phase biopolymers synthesis 55
Studi sul Processo di Maturazione della GP160 54
The proprotein convertase SKI-1/S1P - In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors 54
An improved system for automated peptides synthesis 54
Peptidi sintetici atti a potenziare l'infettività del virus HIV-1 53
Monitoring the key reactions of the solid phase peptide synthesis process 53
Studio dell'Interazione Gp120-CD4 Tramite l'Impiego di Peptidi di Sintesi 52
Analisi Integrata bioneccanica-biochimica dell'osteointegrazione 52
Effects of synthetic peptides on adhesion of osteoblasts cultured in vitro: a preliminary study 51
Structural study of the HIV-1 gp160 cleavage site by native and modified sequences. 3. Role of site specific mutations 51
Evaluation of osteoblast adhesion on biomimetic Ti surfaces: comparison among different strategies for the immobilization of peptides 51
Apparatus and process for the liquid phase oligonucleotide synthesis 51
Binding of CD4 to Synthetic Peptides Patterned on the Principal Neutralizing Domain of Gp120 49
Synthetic Peptides Mapped on Angiostatin K4 Domain Inhibit Endothelial Cell Migration 49
Peptides adsorption on TiO2 and Au: molecular organization investigated by NEXAFS, XPS and IR 49
Anti-HIV activity of peptides derived from the C-terminal sequence of SDF-1b 48
Interazione tra CD4 e Peptidi Derivati da Gp120 48
A conformational study on anti-HIV C-terminal SDF-1 derived peptides 48
Sintesi di un analogo selettivamente fluoresceinato di un peptide del PND che aumenta l'infettività  del virus HIV-1 47
Application of stastical process control to solid phase peptide synthesis 46
Inhibitory effest on HIV-1 of synthetic peptides derived from the C-terminal sequence of SDF-1b 46
Totale 8.280
Categoria #
all - tutte 31.615
article - articoli 15.493
book - libri 1.557
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.374
selected - selezionate 0
volume - volumi 3.556
Totale 53.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020944 0 0 0 0 0 136 84 170 111 221 100 122
2020/20211.298 30 112 19 88 58 168 39 133 255 57 177 162
2021/20221.220 13 256 107 54 48 70 33 112 66 20 168 273
2022/20231.395 325 124 12 168 231 185 8 81 161 24 51 25
2023/2024777 36 78 54 59 41 39 42 49 81 46 161 91
2024/20251.039 81 181 181 97 474 25 0 0 0 0 0 0
Totale 9.895